40 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
and financial position, business strategy, prospective products, product approvals, research and development costs, timing and likelihood of success
PRE 14A
lp02 9gwgfe3iax61b
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.2
c8ah9
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
424B5
4swx6on3nn6v
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
taypv6
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
fq98gcv
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
retmw u20
18 May 20
Prospectus supplement for primary offering
4:11pm